Gabapral Bifidobacterium adolescentis PRL2019

Gabapral is a specialized probiotic supplement containing the specific strain Bifidobacterium adolescentis PRL2019. It is designed as an orosoluble stick pack (suitable for melting in the mouth) and is marketed for its gluten-free and lactose-free properties.

The brand belongs to PharmExtracta, an Italian company founded in 2005 that specializes in the research and development of nutraceuticals and phytotherapeutic products. The brand is deeply rooted in Italian pharmaceutical innovation, focusing on bioavailable formulations. Currently, the brand remains under the ownership of PharmExtracta S.p.A., which operates out of Italy and manages its own manufacturing and distribution networks primarily within the European market.